Newlink Genetics (NLNK) Posts Wider than Expected Q4 Loss of 44c/Share

Newlink Genetics (NASDAQ: NLNK) reported Q4 EPS of ($0.44), $0.10 worse than the analyst estimate of ($0.34). Revenue for the quarter came in at $301 million versus the consensus estimate of $450 thousand.

For earnings history and earnings-related data on Newlink Genetics (NLNK) click here.

---

Serious News for Serious Traders! Try StreetInsider.com Premium Free!

---

You May Also Be Interested In

• Jefferies sees a buying opportunity in this S&P 500 sector
• UBS Reiterates Buy Rating on Sysco (SYY) Following Trip to Company Headquarters
• Wolfe Research upgrades Biogen, AbbVie on pipeline strength and valuation